SLC22A5 and hypertrophic cardiomyopathy: In conclusion, the paucity of information on PCD patients with hypertrophic cardiomyopathy involvement in SLC22A5 variants warrants future studies to reveal the role of this gene in the development of coincident PCD and hypertrophic cardiomyopathy.